Target intelligence / Profile preview

Descemet's membrane (DM)

Target
DM
Molecular classification
Basement membrane, Extracellular matrix
01

Overview

Descemet's membrane is the specialized basement membrane of the corneal endothelium, situated between the corneal stroma and the endothelial layer [1]. It is primarily composed of a hexagonal lattice of collagen type VIII and a basement membrane-like meshwork of collagen type IV, laminin, and fibronectin [2]. Biologically, it serves as a structural scaffold for the attachment and migration of corneal endothelial cells, which are vital for maintaining corneal dehydration and transparency [1, 3]. Pathologically, the membrane is central to conditions like Fuchs' endothelial corneal dystrophy, where it thickens and develops collagenous excrescences known as guttae, and keratoconus, where it may rupture [3, 4]. While it is a critical site for surgical interventions like Descemet Membrane Endothelial Keratoplasty (DMEK), it does not function as a molecular receptor or enzyme for drug binding, making it an anatomical structure rather than a traditional therapeutic target [5]. Sources: [1] StatPearls, 'Anatomy, Eye, Cornea' (https://www.ncbi.nlm.nih.gov/books/NBK544216/) [2] Wikipedia, 'Descemet's membrane' (https://en.wikipedia.org/wiki/Descemet%27s_membrane) [3] NIH/NEI, 'Fuchs' Dystrophy' (https://www.nei.nih.gov/learn-about-eye-health/eye-conditions-and-diseases/fuchs-dystrophy) [4] PubMed, 'The role of Descemet's membrane in corneal disease' (https://pubmed.ncbi.nlm.nih.gov/11063244/) [5] American Academy of Ophthalmology, 'Descemet Membrane Endothelial Keratoplasty' (https://www.aao.org/eye-health/treatments/dmek-surgery)

Other names
Posterior limiting laminaLamina elastica posteriorDescemet membrane
02

Mechanism of action

Not applicable as this is an anatomical structure rather than a molecular drug target.

03

Biological functions

Structural supportEndothelial cell anchoringBarrier functionFiltration
04

Disease associations

Fuchs' endothelial corneal dystrophyKeratoconusDescemet's membrane detachmentPosterior polymorphous corneal dystrophy
05

Safety considerations

Surgical detachmentTearing during keratoplastyFibrosis
06

Biomarkers

Descemet membrane thicknessGuttaeCOL8A2 mutations

Beyond the preview

Go deeper on Descemet's membrane (DM).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Descemet's membrane (DM).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call